ACG与CAG临床指南:消化不良的管理
美国胃肠病学会(ACG)与加拿大胃肠病学会(CAG)联合更新了消化不良管理指南。建议≥60岁消化不良患者行上消化道内镜以排除器质性病变,该推荐为条件性推荐;<60岁患者推荐先行幽门螺杆菌非侵入性检测及阳性治疗,阴性或无效者试用质子泵抑制剂(PPI),无效可试用三环类抗抑郁药(TCA)或促动力药。内镜无异常者定义为功能性消化不良(FD),幽门螺杆菌阳性应根除;治疗失败或幽门螺杆菌阴性者推荐按PPI、TCA、促动力药顺序治疗。不推荐常规行上消化道动力检测,但特定患者可能有用。
要点
- ≥60岁消化不良患者建议行上消化道内镜排除器质性病变(条件性推荐)。
- <60岁患者推荐先行幽门螺杆菌非侵入性检测,阳性者治疗。
- 幽门螺杆菌阴性或无效者试用PPI,无效可试用TCA或促动力药。
核心结论
- ACG与CAG联合更新消化不良管理指南,对≥60岁患者建议内镜检查,<60岁患者推荐幽门螺杆菌检测与治疗,并推荐PPI、TCA和促动力药(按此顺序)用于治疗失败或幽门螺杆菌阴性者。
研究设计与样本
- 由美国胃肠病学会(ACG)与加拿大胃肠病学会(CAG)联合制定的临床指南。
主要发现
- ≥60岁消化不良患者建议行上消化道内镜以排除器质性病变,该推荐为条件性推荐。
- 恶性肿瘤高风险患者(如童年生活在胃癌高发国家或有阳性家族史)可在更年轻时接受内镜检查。
- 年轻患者的报警症状不应自动触发内镜,应个体化考虑。
- <60岁患者推荐行幽门螺杆菌非侵入性检测,阳性者治疗。
- 幽门螺杆菌阴性或对检测治疗无应答者应试用PPI治疗。
关键数值与推荐
- ≥60岁消化不良患者:建议上消化道内镜(条件性推荐)。
- <60岁患者:推荐幽门螺杆菌非侵入性检测,阳性者治疗。
- 幽门螺杆菌阴性或无效者:试用PPI;无效可试用TCA或促动力药。
- 内镜无异常定义为FD;幽门螺杆菌阳性者应根除。
- 治疗失败或幽门螺杆菌阴性者:推荐PPI、TCA和促动力药(按此顺序)。
临床怎么用
- ≥60岁消化不良患者应行上消化道内镜排除器质性病变。
- 高风险患者可在更年轻时接受内镜检查。
- 年轻患者报警症状应个体化考虑内镜。
- <60岁患者先行幽门螺杆菌非侵入性检测,阳性者治疗。
- 幽门螺杆菌阴性或无效者试用PPI,无效可试用TCA或促动力药。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We have updated both the American College of Gastroenterology (ACG) and the Canadian Association of Gastroenterology (CAG) guidelines on dyspepsia in a joint ACG/CAG dyspepsia guideline. We suggest that patients ≥60 years of age presenting with dyspepsia are investigated with upper gastrointestinal endoscopy to exclude organic pathology. This is a conditional recommendation and patients at higher risk of malignancy (such as spending their childhood in a high risk gastric cancer country or having a positive family history) could be offered an endoscopy at a younger age. Alarm features should not automatically precipitate endoscopy in younger patients but this should be considered on a case-by-case basis. We recommend patients <60 years of age have a non-invasive test Helicobacter pylori and treatment if positive. Those that are negative or do not respond to this approach should be given a trial of proton pump inhibitor (PPI) therapy. If these are ineffective tricyclic antidepressants (TCA) or prokinetic therapies can be tried. Patients that have an endoscopy where no pathology is found are defined as having functional dyspepsia (FD). H. pylori eradication should be offered in these patients if they are infected. We recommend PPI, TCA and prokinetic therapy (in that order) in those that fail therapy or are H. pylori negative. We do not recommend routine upper gastrointestinal (GI) motility testing but it may be useful in selected patients.
引用
- Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017. PMID: 28631728. doi:10.1038/ajg.2017.154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。